TITLE

The 2009 Influenza Pandemic: Promising Lessons For Antiviral Therapy For Future Outbreaks

AUTHOR(S)
Bavagnoli, L.; Maga, G.
PUB. DATE
December 2011
SOURCE
Current Medicinal Chemistry;Dec2011, Vol. 18 Issue 35, p5466
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The influenza A virus is the main circulating influenza virus in the human population. It can cause disease also in birds and other mammals and is responsible for annual epidemics and occasional pandemics. The most known and deadly pandemic was the "Spanish flu" (influenza type A/H1N1), which struck the human population between 1918 and 1919, with probably the heaviest toll ever recorded in terms of human lives. The most recent flu pandemic, caused in 2009 by the swine-origin reassortant virus (pH1N1), has raised several critical issues in terms of our preparedness in responding fast to new pandemic influenza strains. Probably, the most instructive lesson that has been learned from the 2009 pandemic, was that the speed of manufacturing and distributing an effective vaccine will not be able to keep up with the pace of a rapidly spreading pandemic virus, failing to grant accessibility to the vaccine for a significant percentage of the susceptible population, before the onset of the pandemic peak. Thus, our first and most effective line of defense against a pandemic influenza virus, particularly in the early phases, are the antiviral drugs. Here we analyze our current understanding of the influenza pandemic viruses, in general, and of the pH1N1 in particular, along with the most recent approaches being pursued to design new anti-influenza drugs.
ACCESSION #
67712234

 

Related Articles

  • Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. de Blasio, Birgitte Freiesleben; Iversen, Bj�rn G.; Tomba, Gianpaolo Scalia // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI...

  • Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. de Blasio, Birgitte Freiesleben; Iversen, Bjørn G.; Tomba, Gianpaolo Scalia // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI...

  • Update: Influenza Activity -- United States, August 30, 2009-March 27, 2010, and Composition of the 2010-11 Influenza Vaccine. Jhung, M.; Brammer, L.; Epperson, S.; Blanton, L.; Dhara, R.; Wallis, T.; Fiore, A.; Gubareva, L.; Bresee, J.; Kamimoto, L.; Xu, X.; Klimov, A.; Cox, N.; Finelli, L.; Njai, R. // MMWR: Morbidity & Mortality Weekly Report;4/16/2010, Vol. 59 Issue 14, p423 

    The article summarizes the influenza activity in the U.S. from August 30, 2009 through March 27, 2010 and reports on the Northern Hemisphere influenza vaccine strain selection from 2010-2011. During the said period, 89,585 out of 422,648 specimens were tested positive for influenza. The week...

  • Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N12009: case- control study in Mexico City. Garcia-Garcia, Lourdes; Valdespino-Gómez, Jose Luis; Lazcano-Ponce, Eduardo; Jimenez-Corona, Aida; Higuera-lglesias, Anjarath; Cruz-Hervert, Pablo; Cano-Arellano, Bulmaro; Garcia-Anaya, Antonio; Ferreira-Guerrero, Elizabeth; Baez-Saldaña, Renata; Ferreyra-Reyes, Leticia; Ponce-de-León-Rosales, Samuel; Alpuche-Aranda, Celia; Rodriguez-López, Mario Henry; Perez-Padilla, Rogelio; Hernandez-Avila, Mauricio // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/10/2009, Vol. 339 Issue 7725, p847 

    The article presents a case-control study of the relationship between having 2008-2009 seasonal trivalent inactivated vaccine and contracting influenza A/H1N1 during the epidemic in Mexico. The study, conducted from March 29 to May 20, 2009, involved participants living in Mexico or the State of...

  • DESIGN AND IMPLEMENTATION OF A STATEWIDE INFLUENZA NURSE TRIAGE LINE IN RESPONSE TO PANDEMIC H1N1 INFLUENZA. Spaulding, Alicen B.; Radi, Deborah; Macleod, Heather; Lynfield, Ruth; Larson, Michelle; Hyduke, Terri; Dehnel, Peter; Acomb, Craig; Devries, Aaron S. // Public Health Reports;Sep/Oct2012, Vol. 127 Issue 5, p532 

    The article describes the efforts of the Minnesota Department of Health (MDH) to establish a coordinated statewide nurse triage line (NTL), the Minnesota (MN) FluLine. During the H1N1 pandemic, the MN Fluline, a statewide NTL was developed to offer instant medical advice to patients over...

  • Anti-viral drugs in flu: not that good?  // Archives of Disease in Childhood;Aug2014, Vol. 99 Issue 8, p766 

    The article focuses on a research related to the administration of antiviral drugs in H1N1 swine flu. Topics discussed include controversies related to the usage of antiviral neuraminidase inhibitors in 2009, the impact of the antiviral drug oseltamivir in flu and research regarding the...

  • Highly conserved antigenic epitope regions of hemagglutinin and neuraminidase genes between 2009 H1N1 and seasonal H1N1 influenza: vaccine considerations. Ping Huang; Shouyi Yu; Changyou Wu; Lijun Liang // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    An immunoinformatics study was conducted to determine the highly conserved antigenic epitope regions of hemagglutinin (HA) and neuraminidase (NA) genes in the humoral immunity and CD4+ and CD8+ T cellular immunity between 2009 pandemic H1N1 (pH1N1) and seasonal H1N1 (sH1N1) viruses. It was found...

  • Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice. Soboleski, Mark R.; Gabbard, Jon D.; Price, Graeme E.; Misplon, Julia A.; Chia-Yun Lo; Perez, Daniel R.; Jianqiang Ye; Tompkins, S. Mark; Epstein, Suzanne L. // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: The rapid spread of the 2009 H1N1 pandemic influenza virus (pH1N1) highlighted problems associated with relying on strain-matched vaccines. A lengthy process of strain identification, manufacture, and testing is required for current strain-matched vaccines and delays vaccine...

  • PANDEMIA DE GRIPÄ‚ H1N1 -- 2009.  // Romanian Journal of Infectious Diseases;2010, Vol. 13 Issue 3, p156 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics